Smoking Cessation Aids Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 01
SKU : PH4165
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
What is the expected growth rate of the smoking cessation aids market?
The global smoking cessation aids market is expected to grow at a significant CAGR of 16.9% during the forecast period (2022-2029). This growth is driven by rising awareness about the harmful effects of smoking, increasing government initiatives to curb tobacco use, and the introduction of new and innovative smoking cessation products.
Who are the major players in the smoking cessation aids market?
Some of the major players in the global smoking cessation aids market include Takeda Pharmaceutical Company Limited, NJOY, Pfizer Inc, Cipla Ltd, GlaxoSmithKline Plc, Dr Reddy's Laboratories, Juul Labs, Glenmark, Perrigo Company plc, Johnson and Johnson Services, Inc, and Imperial Brands.